Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Frida, Emanuelsson"'
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Objective To investigate the contributions of low-grade inflammation measured by C-reactive protein (CRP), hyperglycaemia, and type 2 diabetes to risk of ischemic heart disease (IHD) and cardiovascular disease (CVD) death in the general popu
Externí odkaz:
https://doaj.org/article/33176a28e9674b8b8969afeec9c4ad0a
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Heterozygous familial hypercholesterolemia (FH) is a common genetic disorder leading to premature cardiovascular disease and death as a result of lifelong high plasma low-density lipoprotein cholesterol levels, if not treated early in lif
Externí odkaz:
https://doaj.org/article/ad978dceccfc4038a0ed11154841026a
Publikováno v:
Diabetologia. 64:1492-1503
It is unclear whether glucose per se has a causal impact on risk of stroke and whether glucose-lowering drugs reduce this risk. This is important for the choice of treatment for individuals at risk. We tested the hypotheses that high plasma glucose h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1751bc66c425d26d8f2a5311d599779
https://doi.org/10.1007/s00125-021-05436-0
https://doi.org/10.1007/s00125-021-05436-0
Publikováno v:
Circulation. 144
Background: Treatment with sodium-glucose co-transporter 2 (SGLT2)-inhibitors reduces risk of hospitalization for heart failure and all-cause mortality, but the mechanisms are unclear. Hypothesis: We hypothesized that a functional genetic variant in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ff00a4f0fc452b3f07d98d89db970fe
https://doi.org/10.1161/circ.144.suppl_1.12826
https://doi.org/10.1161/circ.144.suppl_1.12826
Autor:
Frida Emanuelsson, Kaitlin Wade, Anette Varbo, Anne Tybjaerg-hansen, George Davey Smith, Borge G Nordestgaard, Marianne Benn, Nicholas Timpson
Publikováno v:
Circulation. 144
Introduction: Observational studies suggest that obesity is a risk factor of chronic kidney disease (CKD). It is unclear whether this reflects a direct causal effect of obesity or an effect mediated by obesity-related metabolic changes. Hypotheses: W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49c56c956f85b8830d4a1207ddc9b51
https://doi.org/10.1161/circ.144.suppl_1.10469
https://doi.org/10.1161/circ.144.suppl_1.10469
Publikováno v:
Journal of the American College of Cardiology. 74:1465-1476
Background Low-density lipoprotein cholesterol (LDL-C) is causally associated with a high risk of coronary artery disease. Whether this also holds for a spectrum of peripheral vascular diseases is unknown. Objectives The purpose of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab7cc5da55fb165a4868eb5ac3252b4c
https://doi.org/10.1016/j.jacc.2019.07.037
https://doi.org/10.1016/j.jacc.2019.07.037
Publikováno v:
Diabetologia. 64(7)
It is unclear whether glucose per se has a causal impact on risk of stroke and whether glucose-lowering drugs reduce this risk. This is important for the choice of treatment for individuals at risk. We tested the hypotheses that high plasma glucose h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e54faf66b6ce84c7673e2d45a1d585e
https://pubmed.ncbi.nlm.nih.gov/33765180
https://pubmed.ncbi.nlm.nih.gov/33765180
Autor:
Marianne Benn, Frida Emanuelsson
Publikováno v:
Clinical chemistry. 67(1)
BackgroundThe causal relationships between increased concentrations of low density lipoprotein (LDL)-cholesterol and glucose and risk of ischemic heart disease are well established. The causal contributions of LDL-cholesterol and glucose to risk of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8673b61d936222c1fe9d6de26c86a0b1
https://pubmed.ncbi.nlm.nih.gov/33221847
https://pubmed.ncbi.nlm.nih.gov/33221847
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 103:4491-4500
Context Individuals with familial hypercholesterolemia (FH) have a high risk of coronary artery disease, but their risk of peripheral arterial disease (PAD) and chronic kidney disease (CKD) is unknown. Objective In individuals with clinical FH, we te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b92c39ea2181f30043578c1b7867168
https://doi.org/10.1210/jc.2018-01058
https://doi.org/10.1210/jc.2018-01058
Autor:
Børge G. Nordestgaard, Anne Tybjærg-Hansen, Marianne Benn, Sarah C. W. Marott, Frida Emanuelsson
Publikováno v:
Diabetes care. 43(4)
OBJECTIVE To evaluate whether high glucose levels in the normoglycemic range and higher have a causal genetic effect on risk of retinopathy, neuropathy, nephropathy, chronic kidney disease (CKD), peripheral arterial disease (PAD), and myocardial infa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946334ad3fef8ae03280b0f8137962fe
https://pubmed.ncbi.nlm.nih.gov/32054721
https://pubmed.ncbi.nlm.nih.gov/32054721